Evidence map›Paper›PMID 41218612›Full record

ArticleCell genomics2026

Impact of disease-associated chromatin accessibility QTLs across immune cell types and contexts.

Zepeng Mu, Haley E Randolph, Raúl Aguirre-Gamboa, Ellen Ketter, Anne Dumaine, Veronica Locher, Cary Brandolino, Xuanyao Liu, Daniel E Kaufmann, Luis B Barreiro and 1 more

Abstract read
In one paragraph

Article in Cell genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Zepeng MuCommittee on Genetics, Genomics & Systems Biology, University of Chicago, Chicago, IL, USA; Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Haley E RandolphCommittee on Genetics, Genomics & Systems Biology, University of Chicago, Chicago, IL, USA; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
Raúl Aguirre-GamboaSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Ellen KetterCommittee on Microbiology, University of Chicago, Chicago, IL, USA.
Anne DumaineSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Veronica LocherCommittee on Immunology, University of Chicago, Chicago, IL, USA.
Cary BrandolinoSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Xuanyao LiuCommittee on Genetics, Genomics & Systems Biology, University of Chicago, Chicago, IL, USA; Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA; Department of Human Genetics, Department of Medicine, University of Chicago, Chicago, IL, USA.
Daniel E KaufmannDivision of Infectious Diseases, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland; Centre de Recherche du CHUM (CRCHUM) and Département de Médecine, Université de Montréal, Montreal, QC, Canada.
Luis B BarreiroCommittee on Genetics, Genomics & Systems Biology, University of Chicago, Chicago, IL, USA; Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA; Committee on Immunology, University of Chicago, Chicago, IL, USA; Department of Human Genetics, Department of Medicine, University of Chicago, Chicago, IL, USA; CZ Biohub Chicago, Chicago, IL, USA. Electronic address: lbarreiro@uchicago.edu.
Yang I LiCommittee on Genetics, Genomics & Systems Biology, University of Chicago, Chicago, IL, USA; Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA; Department of Human Genetics, Department of Medicine, University of Chicago, Chicago, IL, USA; CZ Biohub Chicago, Chicago, IL, USA. Electronic address: yangili1@uchicago.edu.

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
Characterizing the impact of Yersinia Pestis to the phenotypic evolution of the human immune systemR01GM134376 · NIGMS · UNIVERSITY OF CHICAGO · PI BARREIRO, LUIS BRUNO · 2019 to 2022
$2.2M
Investigating the co-transcriptional impact of genetic variation on gene regulation and diseaseR01GM130738 · NIGMS · UNIVERSITY OF CHICAGO · PI LI, YANG · 2019 to 2023
$2.2M
Characterizing the genetic and evolutionary determinants of population variation in transcriptional responses to pathogensR35GM152227 · NIGMS · UNIVERSITY OF CHICAGO · PI Luis Bruno Barreiro · 2024 to 2026
$1.6M
Computational genomics approaches to study mechanisms and function of mRNA splicingR35GM153249 · NIGMS · UNIVERSITY OF CHICAGO · PI Yang Li · 2024 to 2026
$1.2M
Genetic determinants of inter-individual variation in the dynamic transcriptional innate immune response to Mycobacterium tuberculosisF31HL156419 · NHLBI · UNIVERSITY OF CHICAGO · PI RANDOLPH, HALEY ELIZABETH · 2021 to 2022
$93k
NHLBI NIH HHS F31 HL156419NIDDK NIH HHS P30 DK042086NIGMS NIH HHS R01 GM130738NIGMS NIH HHS R01 GM134376NIGMS NIH HHS R35 GM152227NIGMS NIH HHS R35 GM153249
6 · The paper itself

Abstract

Only one-third of immune-associated genome-wide association study (GWAS) loci colocalize with expression quantitative trait loci (eQTLs), leaving most mechanisms unresolved. To address this, we created a unified single-cell chromatin accessibility (scATAC) map of ∼280,000 peripheral immune cells from 48 individuals, including 20 COVID-19 patients. Topic modeling of scATAC data identified continuous cell states and revealed disease-relevant cellular contexts. We identified 37,390 chromatin accessibility QTLs (caQTLs) at 10% false discovery rate and observed extensive sharing of caQTLs, with <20% confined to a single context. Notably, caQTLs explained ∼50% more GWAS loci compared to eQTLs, nominating putative causal genes for some unexplained loci. Yet most GWAS-colocalizing caQTLs lacked eQTL support, limiting causal inference from chromatin data alone. Thus, while caQTLs can improve GWAS interpretation, robust mechanistic insights require integration with gene expression and other functional evidence. Our work underscores that cellular context is critical for regulatory variant interpretation and emphasizes the need to map genetic effects in disease-relevant cell states.

Indexed as

ChromatinCOVID-19Quantitative Trait LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotideSARS-CoV-2Single-Cell AnalysisChromatincaQTLCOVID-19eQTLGWAShuman complex diseasesimmunology

Identifiers

PMID41218612
PMCPMC12926193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.